NCT00516958 - Pilot Study of the Safety and Clinical Efficacy of Topical Dermacyn™ Wound Care to Treat Mild Diabetic Foot Infections | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

May 31, 2007

Primary Completion Date

December 31, 2007

Study Completion Date

December 31, 2007

Conditions

Foot Ulcer, Diabetic

Interventions

DRUG

Topical Dermacyn

Topical Dermacyn once a day for 10 Days

DRUG

Topical Dermacyn and Levofloxacin

Topical Dermacyn once a day and levofloxacin 750 mg PO per day; both for 10 days

DRUG

Topical Saline and Levofloxacin

Topical saline once a day and levofloxacin 750 mg PO daily, both for 10 days

Trial Locations (16)

15224

Pittsburgh

17112

Harrisburgh

18201

Hazleton

33486

Boca Raton

34609

Spring Hill

34669

Santa Rosa

40222

Louisville

47714

Evansville

54102

Salt Lake City

80220

Denver

85710

Tucson

92037

La Jolla

90063-2326

Los Angeles

92103-8896

San Diego

06515

New Haven

02215

Boston